Drug Free Solution, Inc.
DSOL · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $115 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $115 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | -173,282.9% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | -174,816.8% |
| EPS Diluted | 0 | 0 | -0 | -0.003 |
| % Growth | – | 100% | 97% | – |
| Operating Cash Flow | – | – | – | -$0 |
| Capital Expenditures | – | – | – | -$0 |
| Free Cash Flow | – | – | – | -$0 |